Supplemental Guarantor Information (Details) (USD $) | 3 Months Ended | 12 Months Ended | |
In Millions, unless otherwise specified | Dec. 31, 2013 | Sep. 30, 2013 | Jun. 30, 2013 | Mar. 31, 2013 | Dec. 31, 2012 | Sep. 30, 2012 | Jun. 30, 2012 | Mar. 31, 2012 | Dec. 31, 2013 | Dec. 31, 2012 | Dec. 31, 2011 | Dec. 31, 2010 |
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Revenue | $308.40 | $310.80 | $312 | $325.70 | $374.70 | $368.20 | $368.20 | $362.80 | $1,256.90 | $1,473.90 | $1,462.40 | ' |
Operating costs and expenses | ' | ' | ' | ' | ' | ' | ' | ' | 1,093.10 | 1,203.80 | 1,202.90 | ' |
Operating income (loss) | 40.1 | 57.7 | 46.8 | 19.2 | 57.9 | 66 | 65.2 | 81 | 163.8 | 270.1 | 259.5 | ' |
Interest expense (income), net | ' | ' | ' | ' | ' | ' | ' | ' | 182 | 218.9 | 215 | ' |
Other expense (income), net | ' | ' | ' | ' | ' | ' | ' | ' | -1.3 | 1.7 | 0.9 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | ' | ' | ' | ' | ' | ' | ' | ' | -57.2 | 35.9 | 43.6 | ' |
Income tax (benefit) expense | ' | ' | ' | ' | ' | ' | ' | ' | -2.5 | 24.7 | 25 | ' |
Net (loss) income | -28.1 | 9.3 | 0.8 | -36.7 | -9.8 | 3.9 | 4.5 | 12.6 | -54.7 | 11.2 | 18.6 | ' |
Other comprehensive income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 76.4 | -0.8 | -48.9 | ' |
Total comprehensive income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 21.7 | 10.4 | -30.3 | ' |
Preferred stock dividends | ' | ' | ' | ' | ' | ' | ' | ' | 10.4 | 10.4 | 10.4 | ' |
Net (loss) income applicable to common shareowners | ' | ' | ' | ' | ' | ' | ' | ' | -65.1 | 0.8 | 8.2 | ' |
Condensed Consolidating Balance Sheets [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash and cash equivalents | 4.6 | ' | ' | ' | 23.6 | ' | ' | ' | 4.6 | 23.6 | 73.7 | ' |
Other current assets | 1.6 | ' | ' | ' | 11.6 | ' | ' | ' | 1.6 | 11.6 | ' | ' |
Total current assets | 251.1 | ' | ' | ' | 303.5 | ' | ' | ' | 251.1 | 303.5 | ' | ' |
Property, plant and equipment, net | 902.8 | ' | ' | ' | 1,587.40 | ' | ' | ' | 902.8 | 1,587.40 | ' | ' |
Investment in CyrusOne | 471 | ' | ' | ' | 0 | ' | ' | ' | 471 | 0 | ' | ' |
Other noncurrent assets | 36.6 | ' | ' | ' | 86.3 | ' | ' | ' | 36.6 | 86.3 | ' | ' |
Total assets | 2,107.30 | ' | ' | ' | 2,872.40 | ' | ' | ' | 2,107.30 | 2,872.40 | ' | ' |
Current portion of long-term debt | 12.6 | ' | ' | ' | 13.4 | ' | ' | ' | 12.6 | 13.4 | ' | ' |
Accounts payable | 89.4 | ' | ' | ' | 135.6 | ' | ' | ' | 89.4 | 135.6 | ' | ' |
Other current liabilities | 36.8 | ' | ' | ' | 40.2 | ' | ' | ' | 36.8 | 40.2 | ' | ' |
Total current liabilities | 254.3 | ' | ' | ' | 355.4 | ' | ' | ' | 254.3 | 355.4 | ' | ' |
Long-term debt, less current portion | 2,252.60 | ' | ' | ' | 2,676 | ' | ' | ' | 2,252.60 | 2,676 | ' | ' |
Other noncurrent liabilities | 74.4 | ' | ' | ' | 176.5 | ' | ' | ' | 74.4 | 176.5 | ' | ' |
Total liabilities | 2,784 | ' | ' | ' | 3,570.60 | ' | ' | ' | 2,784 | 3,570.60 | ' | ' |
Shareowners' (deficit) equity | -676.7 | ' | ' | ' | -698.2 | ' | ' | ' | -676.7 | -698.2 | -715.2 | -667.8 |
Total liabilities and shareowners' equity (deficit) | 2,107.30 | ' | ' | ' | 2,872.40 | ' | ' | ' | 2,107.30 | 2,872.40 | ' | ' |
Condensed Consolidating Statements of Cash Flows [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | ' | ' | ' | ' | ' | ' | 78.8 | 212.7 | 289.9 | ' |
Capital expenditures | ' | ' | ' | ' | ' | ' | ' | ' | -196.9 | -367.2 | -255.5 | ' |
Dividends received from CyrusOne | ' | ' | ' | ' | ' | ' | ' | ' | 21.3 | 0 | 0 | ' |
Proceeds from sale of assets | ' | ' | ' | ' | ' | ' | ' | ' | 2 | 1.6 | 11.5 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | ' | ' | ' | ' | ' | -12.2 | 0 | 0 | ' |
Other investing activities | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | -0.7 | ' |
Cash flows provided by (used in) investing activities | ' | ' | ' | ' | ' | ' | ' | ' | -185.4 | -371.8 | -244.7 | ' |
Proceeds from issuance of long-term debt | ' | ' | ' | ' | ' | ' | ' | ' | 536 | 525 | 0 | ' |
Debt issuance costs | ' | ' | ' | ' | ' | ' | ' | ' | -6.7 | -20.9 | -0.8 | ' |
Net increase in corporate credit and receivables facilities with initial maturities less than 90 days | ' | ' | ' | ' | ' | ' | ' | ' | 94.2 | 52 | 0.4 | ' |
Repayment of debt | ' | ' | ' | ' | ' | ' | ' | ' | -530.8 | -442.4 | -11.5 | ' |
Common stock issuance costs | ' | ' | ' | ' | ' | ' | ' | ' | 0 | -5.7 | 0 | ' |
Common stock repurchase | ' | ' | ' | ' | ' | ' | ' | ' | 0 | -0.3 | -10.4 | ' |
Proceeds from exercise of options and warrants | ' | ' | ' | ' | ' | ' | ' | ' | 7.1 | 12.1 | 0.4 | ' |
Other financing activities | ' | ' | ' | ' | ' | ' | ' | ' | -2.3 | -2.8 | -16.5 | ' |
Cash flows provided by (used in) financing activities | ' | ' | ' | ' | ' | ' | ' | ' | 87.6 | 109 | -48.8 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | ' | ' | ' | ' | ' | ' | -19 | -50.1 | -3.6 | ' |
Cash and cash equivalents at beginning of year | ' | ' | ' | 23.6 | ' | ' | ' | 73.7 | 23.6 | 73.7 | 77.3 | ' |
Cash and cash equivalents at end of year | 4.6 | ' | ' | ' | 23.6 | ' | ' | ' | 4.6 | 23.6 | 73.7 | ' |
Notes guaranteed by parent [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Revenue | ' | ' | ' | ' | ' | ' | ' | ' | 1,256.90 | 1,473.90 | 1,462.40 | ' |
Operating costs and expenses | ' | ' | ' | ' | ' | ' | ' | ' | 1,093.10 | 1,203.80 | 1,202.90 | ' |
Operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 163.8 | 270.1 | 259.5 | ' |
Interest expense (income), net | ' | ' | ' | ' | ' | ' | ' | ' | 182 | 218.9 | 215 | ' |
Other expense (income), net | ' | ' | ' | ' | ' | ' | ' | ' | 39 | 15.3 | 0.9 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | ' | ' | ' | ' | ' | ' | ' | ' | -57.2 | 35.9 | 43.6 | ' |
Income tax (benefit) expense | ' | ' | ' | ' | ' | ' | ' | ' | -2.5 | 24.7 | 25 | ' |
Equity in earnings of subsidiaries, net of tax | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Net (loss) income | ' | ' | ' | ' | ' | ' | ' | ' | -54.7 | 11.2 | 18.6 | ' |
Other comprehensive income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 76.4 | -0.8 | -48.9 | ' |
Total comprehensive income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 21.7 | 10.4 | -30.3 | ' |
Preferred stock dividends | ' | ' | ' | ' | ' | ' | ' | ' | 10.4 | 10.4 | 10.4 | ' |
Net (loss) income applicable to common shareowners | ' | ' | ' | ' | ' | ' | ' | ' | -65.1 | 0.8 | 8.2 | ' |
Condensed Consolidating Balance Sheets [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash and cash equivalents | 4.6 | ' | ' | ' | 23.6 | ' | ' | ' | 4.6 | 23.6 | 73.7 | ' |
Receivables, net | 154.8 | ' | ' | ' | 199 | ' | ' | ' | 154.8 | 199 | ' | ' |
Other current assets | 91.7 | ' | ' | ' | 80.9 | ' | ' | ' | 91.7 | 80.9 | ' | ' |
Total current assets | 251.1 | ' | ' | ' | 303.5 | ' | ' | ' | 251.1 | 303.5 | ' | ' |
Property, plant and equipment, net | 902.8 | ' | ' | ' | 1,587.40 | ' | ' | ' | 902.8 | 1,587.40 | ' | ' |
Investment in CyrusOne | 471 | ' | ' | ' | ' | ' | ' | ' | 471 | ' | ' | ' |
Goodwill and intangibles, net | 106.1 | ' | ' | ' | 487.4 | ' | ' | ' | 106.1 | 487.4 | ' | ' |
Investments in and advances to subsidiaries | 0 | ' | ' | ' | 0 | ' | ' | ' | 0 | 0 | ' | ' |
Other noncurrent assets | 376.3 | ' | ' | ' | 494.1 | ' | ' | ' | 376.3 | 494.1 | ' | ' |
Total assets | 2,107.30 | ' | ' | ' | 2,872.40 | ' | ' | ' | 2,107.30 | 2,872.40 | ' | ' |
Current portion of long-term debt | 12.6 | ' | ' | ' | 13.4 | ' | ' | ' | 12.6 | 13.4 | ' | ' |
Accounts payable | 89.9 | ' | ' | ' | 135.6 | ' | ' | ' | 89.9 | 135.6 | ' | ' |
Other current liabilities | 151.8 | ' | ' | ' | 206.4 | ' | ' | ' | 151.8 | 206.4 | ' | ' |
Total current liabilities | 254.3 | ' | ' | ' | 355.4 | ' | ' | ' | 254.3 | 355.4 | ' | ' |
Long-term debt, less current portion | 2,252.60 | ' | ' | ' | 2,676 | ' | ' | ' | 2,252.60 | 2,676 | ' | ' |
Other noncurrent liabilities | 277.1 | ' | ' | ' | 539.2 | ' | ' | ' | 277.1 | 539.2 | ' | ' |
Intercompany payables | 0 | ' | ' | ' | 0 | ' | ' | ' | 0 | 0 | ' | ' |
Total liabilities | 2,784 | ' | ' | ' | 3,570.60 | ' | ' | ' | 2,784 | 3,570.60 | ' | ' |
Shareowners' (deficit) equity | -676.7 | ' | ' | ' | -698.2 | ' | ' | ' | -676.7 | -698.2 | ' | ' |
Total liabilities and shareowners' equity (deficit) | 2,107.30 | ' | ' | ' | 2,872.40 | ' | ' | ' | 2,107.30 | 2,872.40 | ' | ' |
Condensed Consolidating Statements of Cash Flows [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | ' | ' | ' | ' | ' | ' | 78.8 | 212.7 | 289.9 | ' |
Capital expenditures | ' | ' | ' | ' | ' | ' | ' | ' | -196.9 | -367.2 | -255.5 | ' |
Dividends received from CyrusOne | ' | ' | ' | ' | ' | ' | ' | ' | 21.3 | ' | ' | ' |
Proceeds from sale of assets | ' | ' | ' | ' | ' | ' | ' | ' | 2 | 1.6 | 11.5 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | ' | ' | ' | ' | ' | -12.2 | ' | ' | ' |
Other investing activities | ' | ' | ' | ' | ' | ' | ' | ' | 0.4 | -6.2 | -0.7 | ' |
Cash flows provided by (used in) investing activities | ' | ' | ' | ' | ' | ' | ' | ' | -185.4 | -371.8 | -244.7 | ' |
Proceeds from issuance of long-term debt | ' | ' | ' | ' | ' | ' | ' | ' | 536 | 525 | ' | ' |
Funding between Parent and subsidiaries, net | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Debt issuance costs | ' | ' | ' | ' | ' | ' | ' | ' | -6.7 | -20.9 | ' | ' |
Net increase in corporate credit and receivables facilities with initial maturities less than 90 days | ' | ' | ' | ' | ' | ' | ' | ' | 94.2 | 52 | 0.4 | ' |
Repayment of debt | ' | ' | ' | ' | ' | ' | ' | ' | -530.8 | -442.4 | -11.5 | ' |
Common stock issuance costs | ' | ' | ' | ' | ' | ' | ' | ' | ' | -5.7 | ' | ' |
Common stock repurchase | ' | ' | ' | ' | ' | ' | ' | ' | ' | -0.3 | -10.4 | ' |
Proceeds from exercise of options and warrants | ' | ' | ' | ' | ' | ' | ' | ' | 7.1 | 12.1 | ' | ' |
Other financing activities | ' | ' | ' | ' | ' | ' | ' | ' | -12.2 | -10.8 | -27.3 | ' |
Cash flows provided by (used in) financing activities | ' | ' | ' | ' | ' | ' | ' | ' | 87.6 | 109 | -48.8 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | ' | ' | ' | ' | ' | ' | -19 | -50.1 | -3.6 | ' |
Cash and cash equivalents at beginning of year | ' | ' | ' | 23.6 | ' | ' | ' | 73.7 | 23.6 | 73.7 | 77.3 | ' |
Cash and cash equivalents at end of year | 4.6 | ' | ' | ' | 23.6 | ' | ' | ' | 4.6 | 23.6 | 73.7 | ' |
Parent Company [Member] | Notes guaranteed by parent [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Revenue | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 3.4 | ' |
Operating costs and expenses | ' | ' | ' | ' | ' | ' | ' | ' | 55.4 | 33.9 | 23.6 | ' |
Operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | -55.4 | -33.9 | -20.2 | ' |
Interest expense (income), net | ' | ' | ' | ' | ' | ' | ' | ' | 164.3 | 164.8 | 161.8 | ' |
Other expense (income), net | ' | ' | ' | ' | ' | ' | ' | ' | 28.2 | 11.5 | -0.9 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | ' | ' | ' | ' | ' | ' | ' | ' | -247.9 | -210.2 | -181.1 | ' |
Income tax (benefit) expense | ' | ' | ' | ' | ' | ' | ' | ' | -79.8 | -68.3 | -56.4 | ' |
Equity in earnings of subsidiaries, net of tax | ' | ' | ' | ' | ' | ' | ' | ' | 113.4 | 153.1 | 143.3 | ' |
Net (loss) income | ' | ' | ' | ' | ' | ' | ' | ' | -54.7 | 11.2 | 18.6 | ' |
Other comprehensive income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 76.5 | -0.8 | -48.8 | ' |
Total comprehensive income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 21.8 | 10.4 | -30.2 | ' |
Preferred stock dividends | ' | ' | ' | ' | ' | ' | ' | ' | 10.4 | 10.4 | 10.4 | ' |
Net (loss) income applicable to common shareowners | ' | ' | ' | ' | ' | ' | ' | ' | -65.1 | 0.8 | 8.2 | ' |
Condensed Consolidating Balance Sheets [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash and cash equivalents | 2.1 | ' | ' | ' | 3.8 | ' | ' | ' | 2.1 | 3.8 | 69.6 | ' |
Receivables, net | 2.6 | ' | ' | ' | 1 | ' | ' | ' | 2.6 | 1 | ' | ' |
Other current assets | 4.4 | ' | ' | ' | 3.1 | ' | ' | ' | 4.4 | 3.1 | ' | ' |
Total current assets | 9.1 | ' | ' | ' | 7.9 | ' | ' | ' | 9.1 | 7.9 | ' | ' |
Property, plant and equipment, net | 0.1 | ' | ' | ' | 0.1 | ' | ' | ' | 0.1 | 0.1 | ' | ' |
Investment in CyrusOne | 0 | ' | ' | ' | ' | ' | ' | ' | 0 | ' | ' | ' |
Goodwill and intangibles, net | 0 | ' | ' | ' | 0 | ' | ' | ' | 0 | 0 | ' | ' |
Investments in and advances to subsidiaries | 1,406.60 | ' | ' | ' | 1,449.90 | ' | ' | ' | 1,406.60 | 1,449.90 | ' | ' |
Other noncurrent assets | 359.1 | ' | ' | ' | 384.6 | ' | ' | ' | 359.1 | 384.6 | ' | ' |
Total assets | 1,774.90 | ' | ' | ' | 1,842.50 | ' | ' | ' | 1,774.90 | 1,842.50 | ' | ' |
Current portion of long-term debt | 5.4 | ' | ' | ' | 0 | ' | ' | ' | 5.4 | 0 | ' | ' |
Accounts payable | 1.5 | ' | ' | ' | 1.2 | ' | ' | ' | 1.5 | 1.2 | ' | ' |
Other current liabilities | 67.7 | ' | ' | ' | 85.6 | ' | ' | ' | 67.7 | 85.6 | ' | ' |
Total current liabilities | 74.6 | ' | ' | ' | 86.8 | ' | ' | ' | 74.6 | 86.8 | ' | ' |
Long-term debt, less current portion | 1,916.10 | ' | ' | ' | 1,841.70 | ' | ' | ' | 1,916.10 | 1,841.70 | ' | ' |
Other noncurrent liabilities | 214.5 | ' | ' | ' | 383.3 | ' | ' | ' | 214.5 | 383.3 | ' | ' |
Intercompany payables | 246.4 | ' | ' | ' | 228.9 | ' | ' | ' | 246.4 | 228.9 | ' | ' |
Total liabilities | 2,451.60 | ' | ' | ' | 2,540.70 | ' | ' | ' | 2,451.60 | 2,540.70 | ' | ' |
Shareowners' (deficit) equity | -676.7 | ' | ' | ' | -698.2 | ' | ' | ' | -676.7 | -698.2 | ' | ' |
Total liabilities and shareowners' equity (deficit) | 1,774.90 | ' | ' | ' | 1,842.50 | ' | ' | ' | 1,774.90 | 1,842.50 | ' | ' |
Condensed Consolidating Statements of Cash Flows [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | ' | ' | ' | ' | ' | ' | -218.1 | -144.8 | -139.6 | ' |
Capital expenditures | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Dividends received from CyrusOne | ' | ' | ' | ' | ' | ' | ' | ' | 0 | ' | ' | ' |
Proceeds from sale of assets | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 11.5 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | ' | ' | ' | ' | ' | 0 | ' | ' | ' |
Other investing activities | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | -0.7 | ' |
Cash flows provided by (used in) investing activities | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 10.8 | ' |
Proceeds from issuance of long-term debt | ' | ' | ' | ' | ' | ' | ' | ' | 536 | 0 | ' | ' |
Funding between Parent and subsidiaries, net | ' | ' | ' | ' | ' | ' | ' | ' | 174.2 | 433.6 | 150.3 | ' |
Debt issuance costs | ' | ' | ' | ' | ' | ' | ' | ' | -6.7 | -3.6 | ' | ' |
Net increase in corporate credit and receivables facilities with initial maturities less than 90 days | ' | ' | ' | ' | ' | ' | ' | ' | 40 | 0 | 0 | ' |
Repayment of debt | ' | ' | ' | ' | ' | ' | ' | ' | -522 | -352 | 0 | ' |
Common stock issuance costs | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | ' | ' |
Common stock repurchase | ' | ' | ' | ' | ' | ' | ' | ' | ' | -0.3 | -10.4 | ' |
Proceeds from exercise of options and warrants | ' | ' | ' | ' | ' | ' | ' | ' | 7.1 | 12.1 | ' | ' |
Other financing activities | ' | ' | ' | ' | ' | ' | ' | ' | -12.2 | -10.8 | -11.3 | ' |
Cash flows provided by (used in) financing activities | ' | ' | ' | ' | ' | ' | ' | ' | 216.4 | 79 | 128.6 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | ' | ' | ' | ' | ' | ' | -1.7 | -65.8 | -0.2 | ' |
Cash and cash equivalents at beginning of year | ' | ' | ' | 3.8 | ' | ' | ' | 69.6 | 3.8 | 69.6 | 69.8 | ' |
Cash and cash equivalents at end of year | 2.1 | ' | ' | ' | 3.8 | ' | ' | ' | 2.1 | 3.8 | 69.6 | ' |
Cincinnati Bell Telephone Company [Member] | Notes guaranteed by parent [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Revenue | ' | ' | ' | ' | ' | ' | ' | ' | 644.2 | 642.8 | 655.8 | ' |
Operating costs and expenses | ' | ' | ' | ' | ' | ' | ' | ' | 459.1 | 436.3 | 435.6 | ' |
Operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 185.1 | 206.5 | 220.2 | ' |
Interest expense (income), net | ' | ' | ' | ' | ' | ' | ' | ' | -2.7 | -1.5 | 3.4 | ' |
Other expense (income), net | ' | ' | ' | ' | ' | ' | ' | ' | 6.5 | 5.9 | 7.5 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | ' | ' | ' | ' | ' | ' | ' | ' | 181.3 | 202.1 | 209.3 | ' |
Income tax (benefit) expense | ' | ' | ' | ' | ' | ' | ' | ' | 66.1 | 73.8 | 76 | ' |
Equity in earnings of subsidiaries, net of tax | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Net (loss) income | ' | ' | ' | ' | ' | ' | ' | ' | 115.2 | 128.3 | 133.3 | ' |
Other comprehensive income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Total comprehensive income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 115.2 | 128.3 | 133.3 | ' |
Preferred stock dividends | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Net (loss) income applicable to common shareowners | ' | ' | ' | ' | ' | ' | ' | ' | 115.2 | 128.3 | 133.3 | ' |
Condensed Consolidating Balance Sheets [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash and cash equivalents | 1.8 | ' | ' | ' | 1.9 | ' | ' | ' | 1.8 | 1.9 | 1.4 | ' |
Receivables, net | 0 | ' | ' | ' | 0 | ' | ' | ' | 0 | 0 | ' | ' |
Other current assets | 24.1 | ' | ' | ' | 34.4 | ' | ' | ' | 24.1 | 34.4 | ' | ' |
Total current assets | 25.9 | ' | ' | ' | 36.3 | ' | ' | ' | 25.9 | 36.3 | ' | ' |
Property, plant and equipment, net | 706.5 | ' | ' | ' | 646.7 | ' | ' | ' | 706.5 | 646.7 | ' | ' |
Investment in CyrusOne | 0 | ' | ' | ' | ' | ' | ' | ' | 0 | ' | ' | ' |
Goodwill and intangibles, net | 2.3 | ' | ' | ' | 2.3 | ' | ' | ' | 2.3 | 2.3 | ' | ' |
Investments in and advances to subsidiaries | 247.7 | ' | ' | ' | 228.2 | ' | ' | ' | 247.7 | 228.2 | ' | ' |
Other noncurrent assets | 6.1 | ' | ' | ' | 6.3 | ' | ' | ' | 6.1 | 6.3 | ' | ' |
Total assets | 988.5 | ' | ' | ' | 919.8 | ' | ' | ' | 988.5 | 919.8 | ' | ' |
Current portion of long-term debt | 3.9 | ' | ' | ' | 3 | ' | ' | ' | 3.9 | 3 | ' | ' |
Accounts payable | 45.9 | ' | ' | ' | 61.7 | ' | ' | ' | 45.9 | 61.7 | ' | ' |
Other current liabilities | 49.4 | ' | ' | ' | 50.2 | ' | ' | ' | 49.4 | 50.2 | ' | ' |
Total current liabilities | 99.2 | ' | ' | ' | 114.9 | ' | ' | ' | 99.2 | 114.9 | ' | ' |
Long-term debt, less current portion | 141.8 | ' | ' | ' | 141.3 | ' | ' | ' | 141.8 | 141.3 | ' | ' |
Other noncurrent liabilities | 172.2 | ' | ' | ' | 138.6 | ' | ' | ' | 172.2 | 138.6 | ' | ' |
Intercompany payables | 0 | ' | ' | ' | 0 | ' | ' | ' | 0 | 0 | ' | ' |
Total liabilities | 413.2 | ' | ' | ' | 394.8 | ' | ' | ' | 413.2 | 394.8 | ' | ' |
Shareowners' (deficit) equity | 575.3 | ' | ' | ' | 525 | ' | ' | ' | 575.3 | 525 | ' | ' |
Total liabilities and shareowners' equity (deficit) | 988.5 | ' | ' | ' | 919.8 | ' | ' | ' | 988.5 | 919.8 | ' | ' |
Condensed Consolidating Statements of Cash Flows [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | ' | ' | ' | ' | ' | ' | 239 | 250.4 | 264.7 | ' |
Capital expenditures | ' | ' | ' | ' | ' | ' | ' | ' | -153.1 | -108.8 | -106.3 | ' |
Dividends received from CyrusOne | ' | ' | ' | ' | ' | ' | ' | ' | 0 | ' | ' | ' |
Proceeds from sale of assets | ' | ' | ' | ' | ' | ' | ' | ' | 2 | 1.4 | 0 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | ' | ' | ' | ' | ' | 0 | ' | ' | ' |
Other investing activities | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Cash flows provided by (used in) investing activities | ' | ' | ' | ' | ' | ' | ' | ' | -151.1 | -107.4 | -106.3 | ' |
Proceeds from issuance of long-term debt | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' |
Funding between Parent and subsidiaries, net | ' | ' | ' | ' | ' | ' | ' | ' | -84.3 | -66 | -156.5 | ' |
Debt issuance costs | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' |
Net increase in corporate credit and receivables facilities with initial maturities less than 90 days | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Repayment of debt | ' | ' | ' | ' | ' | ' | ' | ' | -3.7 | -76.5 | -2.3 | ' |
Common stock issuance costs | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | ' | ' |
Common stock repurchase | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' |
Proceeds from exercise of options and warrants | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' |
Other financing activities | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Cash flows provided by (used in) financing activities | ' | ' | ' | ' | ' | ' | ' | ' | -88 | -142.5 | -158.8 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | ' | ' | ' | ' | ' | ' | -0.1 | 0.5 | -0.4 | ' |
Cash and cash equivalents at beginning of year | ' | ' | ' | 1.9 | ' | ' | ' | 1.4 | 1.9 | 1.4 | 1.8 | ' |
Cash and cash equivalents at end of year | 1.8 | ' | ' | ' | 1.9 | ' | ' | ' | 1.8 | 1.9 | 1.4 | ' |
Non-Guarantor Subsidiaries [Member] | Notes guaranteed by parent [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Revenue | ' | ' | ' | ' | ' | ' | ' | ' | 669 | 893.3 | 860.6 | ' |
Operating costs and expenses | ' | ' | ' | ' | ' | ' | ' | ' | 634.9 | 795.8 | 801.1 | ' |
Operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 34.1 | 97.5 | 59.5 | ' |
Interest expense (income), net | ' | ' | ' | ' | ' | ' | ' | ' | 20.4 | 55.6 | 49.8 | ' |
Other expense (income), net | ' | ' | ' | ' | ' | ' | ' | ' | 4.3 | -2.1 | -5.7 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | ' | ' | ' | ' | ' | ' | ' | ' | 9.4 | 44 | 15.4 | ' |
Income tax (benefit) expense | ' | ' | ' | ' | ' | ' | ' | ' | 11.2 | 19.2 | 5.4 | ' |
Equity in earnings of subsidiaries, net of tax | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Net (loss) income | ' | ' | ' | ' | ' | ' | ' | ' | -1.8 | 24.8 | 10 | ' |
Other comprehensive income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | -0.1 | 0 | -0.1 | ' |
Total comprehensive income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | -1.9 | 24.8 | 9.9 | ' |
Preferred stock dividends | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Net (loss) income applicable to common shareowners | ' | ' | ' | ' | ' | ' | ' | ' | -1.8 | 24.8 | 10 | ' |
Condensed Consolidating Balance Sheets [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash and cash equivalents | 0.7 | ' | ' | ' | 17.9 | ' | ' | ' | 0.7 | 17.9 | 2.7 | ' |
Receivables, net | 152.2 | ' | ' | ' | 198 | ' | ' | ' | 152.2 | 198 | ' | ' |
Other current assets | 63.9 | ' | ' | ' | 43.8 | ' | ' | ' | 63.9 | 43.8 | ' | ' |
Total current assets | 216.8 | ' | ' | ' | 259.7 | ' | ' | ' | 216.8 | 259.7 | ' | ' |
Property, plant and equipment, net | 196.2 | ' | ' | ' | 940.6 | ' | ' | ' | 196.2 | 940.6 | ' | ' |
Investment in CyrusOne | 471 | ' | ' | ' | ' | ' | ' | ' | 471 | ' | ' | ' |
Goodwill and intangibles, net | 103.8 | ' | ' | ' | 485.1 | ' | ' | ' | 103.8 | 485.1 | ' | ' |
Investments in and advances to subsidiaries | 0 | ' | ' | ' | 0 | ' | ' | ' | 0 | 0 | ' | ' |
Other noncurrent assets | 178.9 | ' | ' | ' | 266.3 | ' | ' | ' | 178.9 | 266.3 | ' | ' |
Total assets | 1,166.70 | ' | ' | ' | 1,951.70 | ' | ' | ' | 1,166.70 | 1,951.70 | ' | ' |
Current portion of long-term debt | 3.3 | ' | ' | ' | 10.4 | ' | ' | ' | 3.3 | 10.4 | ' | ' |
Accounts payable | 42.5 | ' | ' | ' | 72.7 | ' | ' | ' | 42.5 | 72.7 | ' | ' |
Other current liabilities | 34.6 | ' | ' | ' | 69.7 | ' | ' | ' | 34.6 | 69.7 | ' | ' |
Total current liabilities | 80.4 | ' | ' | ' | 152.8 | ' | ' | ' | 80.4 | 152.8 | ' | ' |
Long-term debt, less current portion | 194.7 | ' | ' | ' | 693 | ' | ' | ' | 194.7 | 693 | ' | ' |
Other noncurrent liabilities | 59 | ' | ' | ' | 181.7 | ' | ' | ' | 59 | 181.7 | ' | ' |
Intercompany payables | 199.7 | ' | ' | ' | 276.4 | ' | ' | ' | 199.7 | 276.4 | ' | ' |
Total liabilities | 533.8 | ' | ' | ' | 1,303.90 | ' | ' | ' | 533.8 | 1,303.90 | ' | ' |
Shareowners' (deficit) equity | 632.9 | ' | ' | ' | 647.8 | ' | ' | ' | 632.9 | 647.8 | ' | ' |
Total liabilities and shareowners' equity (deficit) | 1,166.70 | ' | ' | ' | 1,951.70 | ' | ' | ' | 1,166.70 | 1,951.70 | ' | ' |
Condensed Consolidating Statements of Cash Flows [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | ' | ' | ' | ' | ' | ' | 57.9 | 107.1 | 164.8 | ' |
Capital expenditures | ' | ' | ' | ' | ' | ' | ' | ' | -43.8 | -258.4 | -149.2 | ' |
Dividends received from CyrusOne | ' | ' | ' | ' | ' | ' | ' | ' | 21.3 | ' | ' | ' |
Proceeds from sale of assets | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0.2 | 0 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | ' | ' | ' | ' | ' | -12.2 | ' | ' | ' |
Other investing activities | ' | ' | ' | ' | ' | ' | ' | ' | 0.4 | -6.2 | 0 | ' |
Cash flows provided by (used in) investing activities | ' | ' | ' | ' | ' | ' | ' | ' | -34.3 | -264.4 | -149.2 | ' |
Proceeds from issuance of long-term debt | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 525 | ' | ' |
Funding between Parent and subsidiaries, net | ' | ' | ' | ' | ' | ' | ' | ' | -89.9 | -367.6 | 6.2 | ' |
Debt issuance costs | ' | ' | ' | ' | ' | ' | ' | ' | 0 | -17.3 | ' | ' |
Net increase in corporate credit and receivables facilities with initial maturities less than 90 days | ' | ' | ' | ' | ' | ' | ' | ' | 54.2 | 52 | 0.4 | ' |
Repayment of debt | ' | ' | ' | ' | ' | ' | ' | ' | -5.1 | -13.9 | -9.2 | ' |
Common stock issuance costs | ' | ' | ' | ' | ' | ' | ' | ' | ' | -5.7 | ' | ' |
Common stock repurchase | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' |
Proceeds from exercise of options and warrants | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' |
Other financing activities | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | -16 | ' |
Cash flows provided by (used in) financing activities | ' | ' | ' | ' | ' | ' | ' | ' | -40.8 | 172.5 | -18.6 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | ' | ' | ' | ' | ' | ' | -17.2 | 15.2 | -3 | ' |
Cash and cash equivalents at beginning of year | ' | ' | ' | 17.9 | ' | ' | ' | 2.7 | 17.9 | 2.7 | 5.7 | ' |
Cash and cash equivalents at end of year | 0.7 | ' | ' | ' | 17.9 | ' | ' | ' | 0.7 | 17.9 | 2.7 | ' |
Consolidation, Eliminations [Member] | Notes guaranteed by parent [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Condensed Consolidating Statements of Operations and Comprehensive Income (Loss) [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Revenue | ' | ' | ' | ' | ' | ' | ' | ' | -56.3 | -62.2 | -57.4 | ' |
Operating costs and expenses | ' | ' | ' | ' | ' | ' | ' | ' | -56.3 | -62.2 | -57.4 | ' |
Operating income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Interest expense (income), net | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Other expense (income), net | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
(Loss) income before equity in earnings of subsidiaries and income taxes | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Income tax (benefit) expense | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Equity in earnings of subsidiaries, net of tax | ' | ' | ' | ' | ' | ' | ' | ' | -113.4 | -153.1 | -143.3 | ' |
Net (loss) income | ' | ' | ' | ' | ' | ' | ' | ' | -113.4 | -153.1 | -143.3 | ' |
Other comprehensive income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Total comprehensive income (loss) | ' | ' | ' | ' | ' | ' | ' | ' | -113.4 | -153.1 | -143.3 | ' |
Preferred stock dividends | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Net (loss) income applicable to common shareowners | ' | ' | ' | ' | ' | ' | ' | ' | -113.4 | -153.1 | -143.3 | ' |
Condensed Consolidating Balance Sheets [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash and cash equivalents | 0 | ' | ' | ' | 0 | ' | ' | ' | 0 | 0 | 0 | ' |
Receivables, net | 0 | ' | ' | ' | 0 | ' | ' | ' | 0 | 0 | ' | ' |
Other current assets | -0.7 | ' | ' | ' | -0.4 | ' | ' | ' | -0.7 | -0.4 | ' | ' |
Total current assets | -0.7 | ' | ' | ' | -0.4 | ' | ' | ' | -0.7 | -0.4 | ' | ' |
Property, plant and equipment, net | 0 | ' | ' | ' | 0 | ' | ' | ' | 0 | 0 | ' | ' |
Investment in CyrusOne | 0 | ' | ' | ' | ' | ' | ' | ' | 0 | ' | ' | ' |
Goodwill and intangibles, net | 0 | ' | ' | ' | 0 | ' | ' | ' | 0 | 0 | ' | ' |
Investments in and advances to subsidiaries | -1,654.30 | ' | ' | ' | -1,678.10 | ' | ' | ' | -1,654.30 | -1,678.10 | ' | ' |
Other noncurrent assets | -167.8 | ' | ' | ' | -163.1 | ' | ' | ' | -167.8 | -163.1 | ' | ' |
Total assets | -1,822.80 | ' | ' | ' | -1,841.60 | ' | ' | ' | -1,822.80 | -1,841.60 | ' | ' |
Current portion of long-term debt | 0 | ' | ' | ' | 0 | ' | ' | ' | 0 | 0 | ' | ' |
Accounts payable | 0 | ' | ' | ' | 0 | ' | ' | ' | 0 | 0 | ' | ' |
Other current liabilities | 0.1 | ' | ' | ' | 0.9 | ' | ' | ' | 0.1 | 0.9 | ' | ' |
Total current liabilities | 0.1 | ' | ' | ' | 0.9 | ' | ' | ' | 0.1 | 0.9 | ' | ' |
Long-term debt, less current portion | 0 | ' | ' | ' | 0 | ' | ' | ' | 0 | 0 | ' | ' |
Other noncurrent liabilities | -168.6 | ' | ' | ' | -164.4 | ' | ' | ' | -168.6 | -164.4 | ' | ' |
Intercompany payables | -446.1 | ' | ' | ' | -505.3 | ' | ' | ' | -446.1 | -505.3 | ' | ' |
Total liabilities | -614.6 | ' | ' | ' | -668.8 | ' | ' | ' | -614.6 | -668.8 | ' | ' |
Shareowners' (deficit) equity | -1,208.20 | ' | ' | ' | -1,172.80 | ' | ' | ' | -1,208.20 | -1,172.80 | ' | ' |
Total liabilities and shareowners' equity (deficit) | -1,822.80 | ' | ' | ' | -1,841.60 | ' | ' | ' | -1,822.80 | -1,841.60 | ' | ' |
Condensed Consolidating Statements of Cash Flows [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cash flows (used in) provided by operating activities | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Capital expenditures | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Dividends received from CyrusOne | ' | ' | ' | ' | ' | ' | ' | ' | 0 | ' | ' | ' |
Proceeds from sale of assets | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Cash divested from deconsolidation of CyrusOne | ' | ' | ' | ' | ' | ' | ' | ' | 0 | ' | ' | ' |
Other investing activities | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Cash flows provided by (used in) investing activities | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Proceeds from issuance of long-term debt | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' |
Funding between Parent and subsidiaries, net | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Debt issuance costs | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' |
Net increase in corporate credit and receivables facilities with initial maturities less than 90 days | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Repayment of debt | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Common stock issuance costs | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | ' | ' |
Common stock repurchase | ' | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' |
Proceeds from exercise of options and warrants | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | ' | ' |
Other financing activities | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Cash flows provided by (used in) financing activities | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
(Decrease) increase in cash and cash equivalents | ' | ' | ' | ' | ' | ' | ' | ' | 0 | 0 | 0 | ' |
Cash and cash equivalents at beginning of year | ' | ' | ' | 0 | ' | ' | ' | 0 | 0 | 0 | 0 | ' |
Cash and cash equivalents at end of year | 0 | ' | ' | ' | 0 | ' | ' | ' | 0 | 0 | 0 | ' |
Various Cincinnati Bell Telephone Notes [Member] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Debt Instruments [Abstract] | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' | ' |
Cincinnati Bell Telephone Notes Outstanding | $134.50 | ' | ' | ' | $134.50 | ' | ' | ' | $134.50 | $134.50 | ' | ' |